{"url_path":"/sec/arct/8-k/2026-07-02/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/1768224/0001193805-26-000910-index.html","accession_number":"0001193805-26-000910","cik":"0001768224","ticker":"ARCT","issuer_name":"Arcturus Therapeutics Holdings Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1768224/0001193805-26-000910-index.html","primary_entity_key":"0001768224","primary_entity_name":"Arcturus Therapeutics Holdings Inc."},"word_count":130,"has_tables":true,"body_markdown":"**Item 7.01**\n**Regulation FD Disclosure.**\n\n \n\nOn July 2, 2026, the Company issued a press release announcing the\ntransactions described herein (the “Press Release”). A copy of the Press Release is furnished herewith as Exhibit 99.1.\n\n \n\nThe information set forth in this Item 7.01 of this Current Report\non Form 8-K, including the Press Release, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange\nAct of 1934, as amended, or otherwise subject to the liability of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933,\nas amended. In addition, this information shall not be deemed incorporated by reference into any of the Company’s filings with the\nSEC, except as shall be expressly set forth by specific reference in any such filing."}